#72
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians treating patients with alcohol use disorder should be aware that some patients may attempt cannabis-infused beverages as alcohol substitutes, which could complicate treatment adherence and lead to dual substance use patterns. Understanding this substitution behavior is critical for comprehensive substance use assessment and for counseling patients about cross-addiction risks and the lack of proven efficacy of CBD beverages for alcohol cessation. This finding suggests clinicians need updated substance use screening protocols that explicitly address cannabis product consumption alongside alcohol use.
This observational study examined whether cannabis-infused beverages might serve as a substitute for alcohol consumption, finding that participants who had access to CBD drinks reduced their alcohol intake by approximately 50%. The research suggests a potential harm reduction application where patients struggling with alcohol use might shift toward cannabis products as an alternative, though the study design appears to lack rigorous controls and long-term follow-up data necessary to establish causality or durability of this effect. Clinicians should note that while reduced alcohol consumption could theoretically benefit liver function and reduce alcohol-related harms, substituting one psychoactive substance for another raises concerns about dependency potential, cannabis-specific risks including impaired cognition, and whether this represents true behavioral change versus temporary substitution. The evidence is preliminary and does not establish that recommending cannabis beverages as an alcohol reduction strategy is appropriate for individual patients, particularly those with substance use disorder histories or comorbid psychiatric conditions. Clinicians encountering patients interested in cannabis as an alcohol alternative should counsel them about the limited evidence, potential harms specific to cannabis use, and encourage evidence-based treatments for alcohol use disorder such as medications or behavioral therapy rather than encouraging substitution with another intoxicating substance.
“What we’re seeing in the data is that some patients are genuinely using cannabis beverages as a harm reduction tool, drinking less alcohol, which has real metabolic and liver health benefits, but we need to be honest that this isn’t a one-to-one substitution for everyone and the long-term pulmonary and cognitive effects of regular cannabis use still require careful individual assessment.”
💊 While emerging research suggesting cannabis beverages may reduce alcohol consumption is intriguing from a public health perspective, clinicians should remain cautious about interpreting this finding as an endorsement for CBD drinks as an alcohol replacement strategy. The study’s observational design and self-reported outcomes leave substantial room for confounding, including selection bias toward individuals already motivated to reduce drinking and potential reporting effects around socially desirable behavior. Moreover, substituting one psychoactive substance for another does not address underlying drivers of problematic alcohol use, such as anxiety, depression, or social determinants, and may simply shift rather than resolve substance-related harms. Patients presenting with alcohol use disorder or hazardous drinking should continue to be offered evidence-based interventions like behavioral therapy, medications with proven efficacy (naltrexone, acamprosate, disulfiram), and peer support, while any discussion of cannabis as a potential harm reduction tool remains premature given
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it: